Home › Liver Diseases › Maryland › Baltimore
Liver Diseases clinical trials in Baltimore, MD
4 studies for Liver Diseases are looking for participants at sites in and around Baltimore (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions
RecruitingPhase 2
- University of Maryland, Baltimore
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
RecruitingPhase 3
- 89bio Clinical Study Site, Baltimore
- 89bio Clinical Study Site, Glen Burnie · 9 mi away
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
RecruitingPhase 3
- 89bio Clinical Study Site, Baltimore
- 89bio Clinical Study Site, Glen Burnie · 9 mi away
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
RecruitingObservational study
- University of Maryland School of Medicine, Baltimore
About Liver Diseases
Get the facts about liver diseases, such as hepatitis, cancer, and cirrhosis. Know your risk and what you can do to prevent liver problems.
More about Liver Diseases on MedlinePlus
Liver Diseases trials in other cities
- Houston, TX10 studies
- Chicago, IL9 studies
- Washington, DC8 studies
- Los Angeles, CA7 studies
- Atlanta, GA7 studies
- Richmond, VA6 studies
- New York City, NY6 studies
- San Antonio, TX6 studies
- Philadelphia, PA6 studies
- Durham, NC5 studies
- Dallas, TX5 studies
- Ann Arbor, MI5 studies
Other studies in Baltimore
- Non-Small Cell Lung Cancer60 studies
- Breast Cancer47 studies
- Prostate Cancer43 studies
- Lung Cancer40 studies
- Cancer (all types)37 studies
- Colorectal Cancer31 studies
- Pancreatic Cancer31 studies
- Metastatic Cancer28 studies
- Obesity25 studies
- Heart Failure24 studies
- Bladder Cancer24 studies
- Stroke22 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.